KC73

SGLT2 inhibitors

Sodium-glucose co-transporter-2 (SGLT2) inhibitors are medications that were initially approved for treating type 2 diabetes. They are sometimes called ‘gliflozins’ or ‘flozins’ based on their brand names, which include Dapagliflozin, Canagliflozin and Empagliflozin.

This leaflet contains information about SGLT2 inhibitors, including benefits, who the medication is suitable for, and potential side effects.

Publication date: 01/2025

Review date: 01/2028

Kidney Care UK has achieved the PIF TICK, a quality mark operated by the Patient Information Forum. The PIF TICK certifies us as a reliable and trustworthy provider of health and social care information.

Click the category names below to view other related information booklets.

SGLT2 inhibitors - Kidney Care UK

Categories

You can download all our patient information booklets as PDF files to view on your computer, email to others, or print at home. Our booklets are free to download.

The information in these booklets is produced on behalf of and with the kidney community, in partnership with the UK Kidney Association (UKKA; formerly The Renal Association).

Order printed information booklets

If you would prefer to have printed copies of our booklets to read, you can order them for free on our online order form.

(Please note: not all of our patient information booklets are available as printed copies.)